Corporate travel logistics specialists, Colpitts World Travel, has been named as a partner to the new OrphanReach alliance, set up to service the growing demand in delivering global drug trials within the pharmaceutical sector.
“OrphanReach is a strategic alliance that pools the vast experience, heritage, and capabilities of its member firms including global Contract Research Organisation QED Clinical Services and Europe’s leading provider of home-based healthcare and patient support, Healthcare at Home.”
The alliance has been formed to provide the pharmaceutical industry with a one stop solution in carrying out medical trials to treat rare and, what are known as, orphan medical conditions. OrphanReach enables biopharmaceutical clients to access and retain the optimum number of patients throughout a clinical trial programme wherever they are in the world.
As part of the alliance, Colpitts will manage patient travel solutions for pharmaceutical companies participating in clinical trials. Handling global travel logistics for specialist medical trials is a key area of expertise for the company, which has supported clients engaged in research and testing of new products to alleviate a number of rare diseases and conditions throughout the world.
Ian Scholes, Head of European Operations at Colpitts World Travel said: “We are delighted to be a partner within OrphanReach, an alliance which we believe will be hugely beneficial to the pharmaceutical industry in their quest to fight rare and orphan medical conditions. Our extensive experience delivering global travel solutions to support medical trials makes us an ideal fit within the group and further positions us as a key player within this specialist area.”
Thomas Ogorka, Chief Executive Officer of QED Clinical Services, commented: “Colpitts has an excellent reputation for their work in clinical trials travel management and we are delighted to have them on board as a partner of this strategic alliance. Having access to their expertise will undoubtedly enhance the offering for clients by presenting them with a fully, joined up package of services to support their important clinical work.”